Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-915-9 | CAS number: 546-93-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Specific investigations: other studies
Administrative data
- Endpoint:
- biochemical or cellular interactions
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well documented study conducted to good scientific principles.
Data source
Reference
- Reference Type:
- publication
- Title:
- Effects of Magnesium Ions on Calcium and Phosphorous Metabolism
- Author:
- Clark I
- Year:
- 1 968
- Bibliographic source:
- American Journal of Physiology, 214 (2): 348-356
Materials and methods
- Principles of method if other than guideline:
- The purpose of the study was to investigate the effects of supplemental but nontoxic amounts of orally administered magnesium ions on calcium and phosphate metabolism in adult male rats fed diets containing varied amounts of calcium and phosphorous. A 12 day balance period was investigated after the animals were habituated to their respective diets for 5 days.
- GLP compliance:
- no
- Remarks:
- Study predates GLP
- Type of method:
- in vivo
- Endpoint addressed:
- basic toxicokinetics
Test material
- Reference substance name:
- Magnesium chloride hexahydrate (see endpoint summary for justification of read-across)
- IUPAC Name:
- Magnesium chloride hexahydrate (see endpoint summary for justification of read-across)
- Reference substance name:
- 7791-18-6
- EC Number:
- 616-575-1
- Cas Number:
- 7791-18-6
- IUPAC Name:
- 7791-18-6
- Details on test material:
- MgCl2.6H2O
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- other: Holtzman
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 275 - 295 g
- Housing: During the balance period, each rat was kept in an individual stainless steel metabolism cage designed to separate urine from faeces.
- Diet (e.g. ad libitum): The basic diet contained 60% cerelose, 24% blood fibrin, 2% Alphacel, 10% Mazola oil, 4% salt mix and adequate amounts of all vitamins. All diets contained the same amounts of magnesium (0.05%) and trace elements. Each group of animals was fed a diet containing different percentages of calcium and phosphorous. Food intake was controlled so that the control rats and those supplemented with magnesium ate approximately the same amount during the balance period.
- Water (e.g. ad libitum): All animals received 40 mL of drinking solution and the magnesium supplemented rats usually drank between 30-40 mL daily while the controls drank it all.
Administration / exposure
- Route of administration:
- oral: drinking water
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: MgCl2.6H2O was added to drinking water. To make the magnesiant solution more palatable and to ensure an adequate volume of urine, glucose to a final concentration of 10% (w/v) was added to the drinking water of all rats.
The control animals consumed approximately 50 mg of magnesium during the balance period i.e. 100 g food, while the magnesium supplemented rats consumed from 800 mg to 1000 mg.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
2% MgCl2.6H2O (w/v)
Basis:
nominal in water
- No. of animals per sex per dose:
- 12 animals/ group, 12 groups in total
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- After the 12 groups of rats were habituated to their respective diets for 5 days, each group of 12 rats was divided into 2 subgroups of 6 animals.
Examinations
- Examinations:
- Urine and faeces were collected.
Calcium determinations were made by reverse flame photometry on urine directly and on faeces following ashing at 650 °C. Phosphorous was determined by a modification of the Fiske-SubbaRow procedure.
Results and discussion
- Details on results:
- Occasionally the rats supplemented with magnesium developed loose stools and diarrhoea for the first few days.
If the diets contained adequate amounts of calcium, supplemental magnesium decreased faecal calcium (increased absorption) and increased urinary calcium irrespective of the dietary level of calcium. The net effect of supplemental magnesium was to increase calcium balance. The mechanism for the increased absorption of calcium from the intestinal tract or the hypercalciuria is not known. Supplemental magnesium had no effect on phosphorous absorption when dietary phosphorous was suboptimal; it increased it when the dietary calcium to phosphorous ratio was low. The effects of magnesium on phosphate absorption appear to be the result of a magnesium-calcium interaction. Urinary phosphorous decreased with increasing magnesium intake. In general, magnesium increased phosphorous balance primarily as a result of renal conservation of phosphorous.
Applicant's summary and conclusion
- Conclusions:
- There are significant interrelations between dietary phosphorous and magnesium as well as between calcium and magnesium in the absorption and homeostatic control of these substances..
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.